BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36545230)

  • 21. Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date.
    Akbar S; Kabra N; Aronow WS
    Ther Clin Risk Manag; 2020; 16():681-688. PubMed ID: 32801725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurohormonal modulation: The new paradigm of pharmacological treatment of heart failure.
    Silva-Cardoso J; Brás D; Canário-Almeida F; Andrade A; Oliveira L; Pádua F; Fonseca C; Bragança N; Carvalho S; Soares R; Santos JF
    Rev Port Cardiol (Engl Ed); 2019 Mar; 38(3):175-185. PubMed ID: 31029493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology survey.
    Fauvel C; Bonnet G; Mullens W; Giraldo CIS; Mežnar AZ; Barasa A; Tokmakova M; Shchendrygina A; Costa FM; Mapelli M; Zemrak F; Tops LF; Jakus N; Sultan A; Bahouth F; Hadjseyd CE; Salvat M; Anselmino M; Messroghli D; Weberndörfer V; Giverts I; Bochaton T; Courand PY; Berthelot E; Legallois D; Beauvais F; Bauer F; Lamblin N; Damy T; Girerd N; Sebbag L; Pezel T; Cohen-Solal A; Rosano G; Roubille F; Mewton N
    Eur J Heart Fail; 2023 Feb; 25(2):213-222. PubMed ID: 36404398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.
    McDonald M; Virani S; Chan M; Ducharme A; Ezekowitz JA; Giannetti N; Heckman GA; Howlett JG; Koshman SL; Lepage S; Mielniczuk L; Moe GW; O'Meara E; Swiggum E; Toma M; Zieroth S; Anderson K; Bray SA; Clarke B; Cohen-Solal A; D'Astous M; Davis M; De S; Grant ADM; Grzeslo A; Heshka J; Keen S; Kouz S; Lee D; Masoudi FA; McKelvie R; Parent MC; Poon S; Rajda M; Sharma A; Siatecki K; Storm K; Sussex B; Van Spall H; Yip AMC
    Can J Cardiol; 2021 Apr; 37(4):531-546. PubMed ID: 33827756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guidelines of the ESC 2021 on heart failure].
    Bauersachs J; Soltani S
    Herz; 2022 Feb; 47(1):12-18. PubMed ID: 34825250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Heart Failure Knights.
    Mozzini C; Pagani M
    Curr Probl Cardiol; 2023 Sep; 48(9):101834. PubMed ID: 37244515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
    Yancy CW; Jessup M; Bozkurt B; Butler J; Casey DE; Colvin MM; Drazner MH; Filippatos GS; Fonarow GC; Givertz MM; Hollenberg SM; Lindenfeld J; Masoudi FA; McBride PE; Peterson PN; Stevenson LW; Westlake C
    J Am Coll Cardiol; 2017 Aug; 70(6):776-803. PubMed ID: 28461007
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.
    Beldhuis IE; Lam CSP; Testani JM; Voors AA; Van Spall HGC; Ter Maaten JM; Damman K
    Circulation; 2022 Mar; 145(9):693-712. PubMed ID: 35226558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2020 Heart Failure Society of South Africa perspective on the 2016 European Society of Cardiology Chronic Heart Failure Guidelines.
    Hitzeroth J; Mpe M; Klug E; Ranjith N; Sliwa K; Steingo L; Lachman L; Tsabedze N; Ntusi NAB; Society Of South Africa HF
    S Afr Med J; 2020 Aug; 110(8b):13057. PubMed ID: 32880257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of heart failure therapy in patients with mildly reduced ejection fraction: a network meta-analysis.
    Leite M; Sampaio F; Saraiva FA; Diaz SO; Barros AS; Fontes-Carvalho R
    ESC Heart Fail; 2023 Jun; 10(3):1822-1834. PubMed ID: 36896801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary American and European Guidelines for Heart Failure Management: JACC: Heart Failure Guideline Comparison.
    Ostrominski JW; DeFilippis EM; Bansal K; Riello RJ; Bozkurt B; Heidenreich PA; Vaduganathan M
    JACC Heart Fail; 2024 May; 12(5):810-825. PubMed ID: 38583167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network meta-analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction.
    De Marzo V; Savarese G; Tricarico L; Hassan S; Iacoviello M; Porto I; Ameri P
    J Intern Med; 2022 Aug; 292(2):333-349. PubMed ID: 35332595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New pharmacotherapy for heart failure with reduced ejection fraction.
    Sotirakos S; Wheen P; Spiers J; Armstrong R
    Expert Rev Cardiovasc Ther; 2020 Jul; 18(7):405-414. PubMed ID: 32546023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological treatment options for heart failure with reduced ejection fraction: A 2022 update.
    Hellenkamp K; Nolte K; von Haehling S
    Expert Opin Pharmacother; 2022 Apr; 23(6):673-680. PubMed ID: 35260016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
    Yancy CW; Jessup M; Bozkurt B; Butler J; Casey DE; Colvin MM; Drazner MH; Filippatos GS; Fonarow GC; Givertz MM; Hollenberg SM; Lindenfeld J; Masoudi FA; McBride PE; Peterson PN; Stevenson LW; Westlake C
    Circulation; 2017 Aug; 136(6):e137-e161. PubMed ID: 28455343
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ivabradine for treatment of heart failure.
    Bocchi EA; Salemi VMC
    Expert Opin Drug Saf; 2019 May; 18(5):393-402. PubMed ID: 31074301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Heart Failure with Reduced Ejection Fraction after ESC 2016 Heart Failure Guidelines: The Linx Registry.
    de Frutos F; Mirabet S; Ortega-Paz L; Buera I; Darnés S; Farré N; Perez B; Adeliño R; Bascompte R; Pérez-Rodón J; Aparicio X; Sutil-Vega M; Soto A; Faraudo M; Cainzos-Achirica M; Manito N
    ESC Heart Fail; 2020 Feb; 7(1):25-35. PubMed ID: 31916413
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.